Determining the rate of varicella vaccine rash in children with moderate-severe eczema

Journal of Paediatrics and Child Health

Volumn 41, Issue 11, 2005, Pages 561-563

  Frydenberg, A R ^a,b   Buttery, J P ^a   Royle, J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Chickenpox vaccine; Dermatitis; Eczema; Varicella; Varicella vaccine

Indexed keywords

CHICKENPOX VACCINE;

ANAPHYLAXIS; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; ECZEMA; FEMALE; HUMAN; INFANT; INJECTION SITE EDEMA; INJECTION SITE ERYTHEMA; INJECTION SITE PAIN; INJECTION SITE REACTION; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RASH; SCHOOL CHILD; THROMBOCYTOPENIA; VACCINATION; AUSTRALIA; CHEMICALLY INDUCED DISORDER; CHILD; CLASSIFICATION; PATHOPHYSIOLOGY; PILOT STUDY;

CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; ECZEMA; FEMALE; HUMANS; INFANT; MALE; PILOT PROJECTS; PROSPECTIVE STUDIES; VICTORIA;

EID: 33644834214     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/j.1440-1754.2005.00721.x     Document Type: Article

References (19)

1. Chant KG, Sullivan EA, Burgess MA et al. Varicella zoster virus infection in Australia. Aust. N.Z. J. Public Health 1998 22 (4 413 18.
2. Balfour HH, Kelly JM, Suarez CS et al. Acyclovir treatment of varicella in otherwise healthy children. J. Pediatr. 1990 162 : 1036 42.
3. Brotherton J, McIntyre P, Puech M et al. Vaccine preventable diseases and vaccination coverage in Australia 2001-2003. Commun. Dis. Intell. 2004 28 (Suppl 2 63 71.
4. Carapetis JR, Russell DM, Curtis N. The burden and cost of hospitalised varicella and zoster in Australian children. Vaccine 2004 23 : 755 61.
5. American Academy of Pediatrics COID. Varicella vaccine update. Pediatrics 2000 105 : 136 41.
6. Immunisation ATAGOI. Australian Immunisation Handbook, 8th edn. Canberra : Commonwealth Department of Health and Ageing, 2003.
7. Skull SA, Wang EEL. Varicella vaccination - a critical review of the evidence. Arch. Dis. Child. 2001 85 : 83 90.
8. Wise RP, Salive ME, Braun MM et al. Postlicensure safety surveillance for varicella vaccine. JAMA 2000 284 : 1271 79.
9. Salzman M, Sharrar R, Steinberg S, LaRussa P. Transmission of varicella-vaccine virus from a healthy 12 month old child to his pregnant mother. J. Pediatr. 1997 131 : 151 4.
10. Long SS. Toddler to mother transmission of varicella-vaccine virus: How bad is that. J. Pediatr. 1997 131 : 10 2.
11. Peterson CL, Mascola L, Chao SM et al. Children hospitalized for varicella: A prevaccine review. J. Pediatr. 1996 129 (4 529 35.
12. Mar A, Tam M, Jolley D, Marks R. The cumulative incidence of atopic dermatitis in the first 12 months among Chinese, Vietnamese, and Caucasian infants born in Melbourne, Australia. J. Am. Acad. Dermatol. 1999 40 (4 597 602.
13. Dermatitis ETFOA. Severity scoring of atopic dermatitis: The SCORAD index. Dermatology 1993 186 : 23 31.
14. Weibel RE, Neff BJ, Kuter BJ et al. Live attenuated varicella virus vaccine. N. Engl. J. Med. 1984 310 : 1409 15.
15. Clements DA, Armstrong CB, Ursano AM, Moggio MM, Walter EB, Wilfert CM. Over five-year follow-up of Oka/Merck varicella vaccine recipients in 465 infants and adolescents. Pediatr. Infect. Dis. J. 1995 14 : 874 9.
16. Sharrar RG, LaRussa P, Galea SA et al. The post marketing safety profile of varicella vaccine. Vaccine 2001 19 : 916 23.
17. White CJ, Kuter BJ, Hildebrand CS et al. Varicella vaccine (VARIVAX) in healthy children and adolescents: Results from clinical trials, 1987 to 1989. Pediatrics 1991 87 (5 604 10.
18. Bjarnason NH, Kampmann JP. Selection bias introduced by the informed consent process. Lancet 2003 361 : 1990 1.
19. Feder HM, LaRussa P, Steinberg S, Gershon AA. Clinical varicella following varicella vaccination: Don't be fooled. Pediatrics 1997 99 : 897 9.